TDOC Teladoc Health, Inc.
Platform & Compounding FCF
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 25%
D- 30
  • 5yr Avg ROIC -7.1%
  • Operating Margin Trend +53.29 pp/yr

Capital Efficiency

Weight: 15%
F 7
  • 5yr Avg ROE -223.9%
  • 5yr Share-Count CAGR 2.9%

Growth Quality

Weight: 25%
C- 47
  • 5yr Revenue CAGR 5.6%
  • 5yr EPS CAGR 0.0%
  • Revenue-Growth Years (5) 3/5

Cash Generation

Weight: 20%
D 37
  • 5yr FCF Margin 9.2%
  • 5yr FCF/NI Conversion 0.00x

Balance Sheet

Weight: 10%
D 33
  • Net Debt / EBITDA 1.76x
  • Interest Coverage (EBIT/Int) -10.95x
  • Altman Z-Score -6.73

Stability

Weight: 5%
B 73
  • EPS Volatility (σ/μ) 0.00
  • Piotroski F-Score 4
  • Negative-Revenue Years (5) 2/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 4 gurus held; 1 new buy; 2 added; 1 trimmed.

Holders
4 +1
Avg Δ position
-17.8%
New buys
1
Full exits
0
As of Q1 2026